CCAB Centro Clinico Academico Braga Associacao

At CCAB Centro Clinico Academico Braga Associacao, dermatology research is strongly focused on skin and connective tissue diseases and broader immune system diseases, with studies centered on conditions such as atopic dermatitis, hidradenitis suppurativa, psoriasis, urticaria, and bullous pemphigoid. These trials are designed to test new treatment options, improve symptom control, and better understand how inflammatory skin disorders respond to therapy.

• Evaluation of new therapies for moderate to severe inflammatory skin conditions
• Research in chronic disorders such as hidradenitis suppurativa, psoriasis, and atopic dermatitis
• Studies aiming to improve long-term disease control and patient quality of life

The site’s dermatology portfolio reflects a broad interest in immune-mediated inflammation and practical treatment advances for patients with persistent skin disease.

A major part of the research landscape covers digestive system diseases, especially Crohn’s disease, ulcerative colitis, and related inflammatory bowel diseases. Trials at the Braga site explore whether newer therapies can induce remission, maintain disease control, and support better outcomes in both adult and pediatric patients.

• Clinical studies in Crohn’s disease and ulcerative colitis
• Research on therapies for moderate to severe intestinal inflammation
• Work aimed at improving remission rates and long-term disease management

This area also includes related digestive conditions such as erosive esophagitis and irritable bowel syndrome, showing a wide gastroenterology focus.

The site has an active program in nervous system diseases and mental disorders, including multiple sclerosis, Parkinson’s disease, epilepsy, migraine, Alzheimer’s disease, dementia, schizophrenia, and obsessive-compulsive disorder. These studies are generally intended to evaluate treatment effectiveness, reduce symptoms, and support longer-term neurological and psychiatric care.

• Trials in multiple sclerosis and other chronic neurological conditions
• Studies in cognitive decline, dementia, and Alzheimer’s disease
• Research on symptom control in migraine, epilepsy, and psychiatric disorders

This portfolio highlights a strong interest in both disease-modifying therapies and approaches that improve day-to-day functioning.

Cancer research at the site spans neoplasms and hemic and lymphatic diseases, with studies in breast cancer, lung cancer, prostate cancer, gastric cancer, urothelial carcinoma, head and neck cancer, lymphoma, multiple myeloma, myelofibrosis, and myeloid leukemia. The overall goal is to test innovative therapies, compare treatment strategies, and improve outcomes in difficult-to-treat cancers.

• Studies of new cancer treatments across solid tumors and blood cancers
• Research focused on advanced, relapsed, or metastatic disease
• Trials evaluating better ways to extend survival and control progression

CCAB Centro Clinico Academico Braga Associacao is especially active in oncology research that seeks more effective and durable treatment responses.

Another important theme is cardiovascular diseases together with nutritional and metabolic diseases and kidney disorders. Trials include myocardial infarction, heart failure, calcific aortic valve stenosis, hypertension, obesity, type 2 diabetes, chronic kidney disease, IgA nephropathy, and focal segmental glomerulosclerosis. These studies aim to improve disease control, slow progression, and reduce long-term complications.

• Research on heart, vascular, metabolic, and renal conditions
• Studies assessing treatment effectiveness and prevention of disease progression
• Trials supporting better management of inflammation-linked cardiometabolic risk

The breadth of this area shows a strong interest in chronic diseases where early intervention can make a major difference.

The site also investigates respiratory tract diseases, bacterial infections and mycoses, and virus diseases, alongside several immune system diseases. Research includes asthma, COPD, idiopathic pulmonary fibrosis, pneumonia, nontuberculous mycobacterial lung infection, and autoimmune disorders such as systemic lupus erythematosus, Sjögren’s syndrome, and rheumatoid arthritis. These trials are aimed at testing new therapies, improving safety, and helping patients with chronic inflammatory or infectious disease.

• Studies in chronic lung disease and fibrotic respiratory conditions
• Research on infections affecting the lungs and respiratory system
• Trials in autoimmune diseases with systemic inflammation

This mix of respiratory, infectious, and autoimmune research reflects a broad clinical focus beyond dermatology alone.